1 – 10 of 105
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Predictive value of kallikrein forms and β-microseminoprotein in blood from patients with evidence of detectable levels of PSA after radical prostatectomy
Pellegrino, Francesco ; Sjoberg, Daniel D ; Tin, Amy L ; Benfante, Nicole E ; Briganti, Alberto ; Montorsi, Francesco ; Scardino, Peter T ; Eastham, James A ; Vickers, Andrew J and Lilja, Hans LU
, et al.
(2023)
In World Journal of Urology
- Contribution to journal › Article
-
Mark
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium
Bjerner, Johan ; Bratt, Ola LU ; Aas, Kirsti ; Albertsen, Peter C ; Fosså, Sophie D ; Kvåle, Rune ; Lilja, Hans LU
; Müller, Christoph
LU
; Müller, Stig
and Stensvold, Andreas
, et al.
(2023)
In European Urology
- Contribution to journal › Article
- 2022
-
Mark
How Should Molecular Markers and Magnetic Resonance Imaging Be Used in the Early Detection of Prostate Cancer?
Vickers, Andrew J ; Russo, Giorgio ; Lilja, Hans LU
; Evans, Christopher
; Schalken, Jack A
; Klein, Eric
and Eggener, Scott
(2022)
In European Urology Oncology
5(2).
p.135-137
- Contribution to journal › Debate/Note/Editorial
-
Mark
Predicting Grade group 2 or higher cancer at prostate biopsy by 4Kscore in blood and uCaP microRNA model in urine
Fredsøe, Jacob ; Rasmussen, Martin ; Tin, Amy L. ; Vickers, Andrew J. ; Borre, Michael ; Sørensen, Karina D. and Lilja, Hans LU
(2022)
In Scientific Reports
12(1).
- Contribution to journal › Article
-
Mark
Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality : 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial
Carlsson, Sigrid V ; Arnsrud Godtman, Rebecka ; Pihl, Carl-Gustav ; Vickers, Andrew ; Lilja, Hans LU
; Hugosson, Jonas
and Månsson, Marianne
LU
(2022)
In European Urology
- Contribution to journal › Article
-
Mark
Prostate cancer polygenic risk score and prediction of lethal prostate cancer
- Contribution to journal › Article
-
Mark
Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence
- Contribution to journal › Article
- 2021
-
Mark
Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume
Vertosick, Emily A. LU ; Zappala, Stephen ; Punnen, Sanoj ; Hugosson, Jonas ; Boorjian, Stephen A. ; Haese, Alexander ; Carroll, Peter ; Cooperberg, Matthew ; Bjartell, Anders LU and Lilja, Hans LU
, et al.
(2021)
In Urology
157.
p.102-106
- Contribution to journal › Article
-
Mark
Prospective validation of microseminoprotein-β added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohort
- Contribution to journal › Article
- 2020
-
Mark
Prespecified 4-Kallikrein Marker Model at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population Based Cohort of Asymptomatic Men Followed for 20 Years
Vertosick, Emily A. ; Häggström, Christel ; Sjoberg, Daniel D. ; Hallmans, Göran ; Johansson, Robert ; Vickers, Andrew J. ; Stattin, Pär and Lilja, Hans LU
(2020)
In The Journal of urology
204(2).
p.281-288
- Contribution to journal › Article